stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. MYRX
    stockgist
    HomeTop MoversCompaniesConcepts
    MYRX logo

    Myrexis, Inc.

    MYRX
    OTC
    Financial Services
    Shell Companies
    New York City, NY, US1 employeesmyrexis.com
    —

    At A Glance

    1

    Myrexis, Inc.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees1
    Fundamentals

    How The Business Makes Money

    Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

    Industry Shell Companies
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    OOGIC2E Energy, Inc.————
    LTUSLotus Pharmaceuticals, In...————
    WORCWake Up Now, Inc.————
    TAKDTransAKT Ltd.————
    CDSGChina Dongsheng Internati...————
    JADAJade Art Group Inc.————
    CNHCChina Health Management C...————
    AAPTAll American Pet Company,...————
    Analyst View
    Company Profile
    CIKUNKNOWN_MYRX
    ISINUS62856H1077
    CUSIP62856H107
    Phone801-214-7800
    Address630 Fifth Avenue, New York City, NY, 10020, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice